Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,604 total articles
Alvotech, a biotechnology firm specializing in biosimilar medicines, has filed its 2025 Annual Report with the U.S. SEC. The report highlights the company's portfolio of approved biosimilars and an active pipeline targeting multiple therapeutic areas, supported by strategic global partnerships for market expansion.
Alvotech, a Nasdaq-listed biotechnology firm specializing in biosimilars, has published its 2025 Annual Report. The company continues its focus on developing and commercializing high-quality biosimilar medicines globally, with five biosimilars already approved and marketed. Their pipeline includes nine biosimilar candidates targeting multiple thera…
Curanex Pharmaceuticals reports significant progress in manufacturing, toxicology, intellectual property, and regulatory preparations for its lead drug candidate Phyto-N, targeting ulcerative colitis. The company completed GMP pilot batch production and pivotal toxicology studies, aiming for an IND submission by late 2026 and plans to initiate Phas…
Future Money Acquisition Corporation, a Cayman Islands-based blank check company, successfully completed its IPO by offering 11.2 million units at $10 each, including a partial exercise of the underwriters' overallotment option. The company raised gross proceeds of $112 million and concurrently closed a private placement for an additional $3 millio…
KPET Ultra Paceline Corporation, a blank check company sponsored by experienced investors Eduardo Tamraz and Karl Peterson, announced the pricing of its initial public offering of 20 million units priced at $10 each. The units will begin trading on the New York Stock Exchange under the ticker KPET.U on March 31, 2026. Each unit comprises one Class …
QDRO Acquisition Corp., a blank check company, completed its initial public offering of 20 million units at $10 per unit, raising $200 million. The units began trading on the Nasdaq under ticker QADRU. The company aims to identify potential business combinations in financial services, digital currency, and technology sectors.
Glucotrack, Inc. reported its 2025 financial results and significant corporate progress including the receipt of three new U.S. patents for its implantable continuous blood glucose monitoring (CBGM) technology, a $4 million private placement, and preparations to file for Investigational Device Exemption (IDE) with the FDA to launch U.S. clinical tr…
Oxbridge Re Holdings Limited reported strong financial results for 2025, highlighting outperforming tokenized reinsurance products and strategic platform expansion. The Balanced Yield Token surpassed its 20% annual return target, now estimated at 25%, and the High Yield Token remains on track for 42% returns. The company expanded its ecosystem thro…
Aptera Motors Corp. announced a GAAP net loss of $15.5 million for Q4 2025 and $43.9 million for the full year, alongside non-GAAP adjusted net losses of $8.7 million and $18.5 million respectively. The company raised $17.1 million in early 2026 to support production efforts and made progress on its validation assembly line and fleet assembly. Desp…
Bio Green Med Solution, Inc. (NASDAQ: BGMS) announced its Q4 and full-year 2025 financial results, highlighting a strategic shift from biopharmaceuticals to fire safety protection and distribution activities following the acquisition of Fitters Sdn. Bhd. The company completed the liquidation of its UK subsidiary and sold its drug candidate plogoser…
DeFi Development Corp. reported a remarkable 442% revenue increase for fiscal year 2025. The company attributes this growth to its unique treasury strategy focused on accumulating and compounding Solana (SOL) holdings, operational validator infrastructure generating staking rewards, and its AI-powered SaaS platform serving the commercial real estat…
Rocket Lab Corporation has obtained regulatory approval from Germany's Federal Ministry for Economic Affairs and Energy to acquire Mynaric AG, a leading provider of laser optical communications terminals for air, space, and mobile applications. The acquisition is expected to close in April 2026 and will enable Rocket Lab to expand its support of Ge…
BridgeBio Pharma reported compelling long-term data from its ATTRibute-CM open-label extension trial showing that acoramidis significantly reduces all-cause and cardiovascular mortality by approximately 45% and 49%, respectively, in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) through 54 months. The treatment also stabilize…
HII, America's largest shipbuilder, has signed a memorandum of understanding with GrayMatter Robotics to advance shipbuilding through Physical AI technology. This partnership aims to enhance manufacturing automation, increase throughput, and reduce rework in shipbuilding and related industries using cutting-edge AI robotics solutions developed by G…
FitLife Brands announced it will release its fourth quarter fiscal 2025 financial results on March 31, 2026, followed by an investor conference call on April 1, 2026. The company specializes in nutritional supplements and wellness products and distributes over 500 SKUs online and in retail.
DeFi Technologies Inc. has appointed Jacob Lindberg as Chief Revenue Officer of its subsidiary Valour to lead the Nordic and broader European expansion of its crypto asset exchange traded products (ETPs). Lindberg's expertise in digital asset indices and institutional investment products is expected to support Valour's growth in key European market…
Ferrari N.V. has disclosed its periodic share repurchase activities under the first tranche of its announced €3.5 billion multi-year buyback program, detailing purchases on both Euronext Milan and the New York Stock Exchange. Since the program's start in January 2026 through March, Ferrari acquired over 737,000 shares, investing approximately €217 …
TJGC Group Limited announced it received a Nasdaq notification for failing to maintain the minimum bid price of $1 over the past 30 consecutive business days. The company has 180 days to regain compliance, with the possibility of an additional 180-day extension if other listing standards are met. If compliance is not restored, TJGC risks delisting …
Viewbix Inc., through its subsidiary Quantum X Labs and its portfolio company Nuclear Quantum, has reached a strategic milestone by progressing its proprietary quantum simulation algorithms towards targeted collaborations with established nuclear simulation companies. This initiative aims to modernize legacy simulation methods by integrating quantu…
Workhorse Group Inc. announced a purchase order from Purolator for 100 fully-electric step vans, doubling Purolator's electric vehicle fleet supplied by Workhorse. The deliveries will take place throughout 2026, strengthening the long-term partnership between the companies. Workhorse's manufacturing and operational scale supports its growing presen…
CN, a major North American railway company, will report its Q1 2026 financial and operating results on April 29, 2026. The company's senior officers, including CEO Tracy Robinson, will discuss the results and outlook in a live conference call and webcast available to investors and the public.
Jeffs' Brands Ltd has officially changed its corporate name to Nexera Technologies Ltd, reflecting a strategic pivot toward advanced technology and homeland security solutions including AI-driven threat detection and advanced screening systems. The company's shares will begin trading under the new ticker NEXR on Nasdaq. This rebranding and strategi…
Immix Biopharma announced completion of enrollment in its pivotal NEXICART-2 Phase 2 trial for relapsed/refractory AL Amyloidosis. Topline results are expected in Q3 2026, followed by Biologics License Application (BLA) submission and planned commercial launch of their lead CAR-T therapy, NXC-201. The company also appointed a new Chief Medical Offi…
Clean Energy Technologies, Inc. (CETY) has entered a non-binding Letter of Intent with Hoppy Power Ltd. to evaluate and advance deployment of its High Temperature Ablative Pyrolysis (HTAP™) technology for waste-to-energy projects, with an initial site identified in Westlock, Alberta. The project aims to convert waste into clean energy with modular …
Clearmind Medicine announced the successful completion of treatment and follow-up for 18 participants in its ongoing FDA-approved Phase I/IIa clinical trial of CMND-100, a non-hallucinogenic MEAI-based oral drug candidate for Alcohol Use Disorder. The progress includes treatment of four additional participants at the Tel Aviv site, demonstrating op…
